Expansion of Generic Medicines Authorization in...

By João L. Carapinha

February 2, 2026

928 New Medicines Authorizations Boost Portugal's Health Access In 2025, Portugal's National Authority for Medicines and Health Products (
CHMP January 2026 Approvals: Expanding Access to Innovative Therapies
Risicoverevening Policy Updates: Key Amendments for 2022-2025 Explained
Characterizing Burnout in Health Professionals: Insights from the BEATS Study...
Latin America Pharma Growth: Boehringer Ingelheim’s Strategic Investmen...
NICE Endorses Dupilumab for Eosinophilic COPD Treatment
Accelerating FAST-EU Clinical Trials
NICE Endorses Talazoparib Enzalutamide for Prostate Cancer Treatment
Sandoz Biosimilars Strategy: Capturing Market Opportunities for Affordable He...
Trump Economic Revival: Key Policies and Impacts from Davos 2026
Alzheimer’s Care Innovation: Advancing Implementation Across Europe
Long-Term Benefits of Composite Treatment Targets in Type 2 Diabetes Management
Navigating Economic Resilience Through Life Sciences Investment